Title |
Analysis of single-nucleotide polymorphisms (SNPs) in human CYP3A4 and CYP3A5 genes: potential implications for the metabolism of HIV drugs
|
---|---|
Published in |
BMC Medical Genomics, July 2014
|
DOI | 10.1186/1471-2350-15-76 |
Pubmed ID | |
Authors |
Giulia Berno, Mauro Zaccarelli, Caterina Gori, Massimo Tempestilli, Andrea Antinori, Carlo Federico Perno, Leopoldo Paolo Pucillo, Roberta D’Arrigo |
Abstract |
Drug metabolism via the cytochrome P450 (CYP450) system has emerged as an important determinant in the occurrence of several drug interactions (adverse drug reactions, reduced pharmacological effect, drug toxicities). In particular, CYP3A4 and CYP3A5 (interacting with more than 60% of licensed drugs) exhibit the most individual variations of gene expression, mostly caused by single nucleotide polymorphisms (SNPs) within the regulatory region of the CYP3A4 and CYP3A5 genes which might affect the level of enzyme production.In this study, we sought to improve the performance of sensitive screening for CYP3A polymorphism detection in twenty HIV-1 infected patients undergoing lopinavir/ritonavir (LPV/r) monotherapy. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 25% |
India | 1 | 25% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 2 | 50% |
Practitioners (doctors, other healthcare professionals) | 2 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 2% |
Unknown | 49 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 12 | 24% |
Student > Ph. D. Student | 7 | 14% |
Student > Postgraduate | 4 | 8% |
Student > Bachelor | 4 | 8% |
Researcher | 3 | 6% |
Other | 8 | 16% |
Unknown | 12 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 11 | 22% |
Agricultural and Biological Sciences | 10 | 20% |
Biochemistry, Genetics and Molecular Biology | 8 | 16% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Nursing and Health Professions | 2 | 4% |
Other | 5 | 10% |
Unknown | 12 | 24% |